European Association for the Study of the Liver
EASL Podcasts
The EASL Podcast collection brings together Talk Liver to Me , EASL’s exclusive original podcast, alongside educational audio content adapted from EASL Studio, DeepDive webinars, and Policy Dialogues. Stay informed with expert insights, practical discussions, and the latest knowledge in hepatology — anytime, anywhere.
Be sure to visit the podcast's website and support the creator: easl-podcasts.buzzsprout.com
Author
European Association for the Study of the Liver
Category
Podcast website
Latest episode
Nov 11, 2026
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
EASL Studio Podcast: Exploring new frontiers: The AI liver taskforce initiative 12.06.2024 30:39
EASL Studio - Exploring new frontiers: The AI liver taskforce initiative Faculty Eric Trépo (Moderator) Tom Lüdde (Faculty) Jakob Kather (Faculty) Raquel Pérez-López (Faculty) All EASL Studio Podcasts are available on EASL Campus .
EASL Studio Podcast: SLD nomenclature: Need for refinement? 12.06.2024 29:09
EASL Studio - SLD nomenclature: Need for refinement? Faculty Aleksander Krag (Moderator) Meena Bansal (Faculty) Sven Francque (Faculty) Alexandre Louvet (Faculty) All EASL Studio Podcasts are available on EASL Campus .
EASL Studio Podcast: Landmark studies at the EASL Congress 2024 12.06.2024 45:55
EASL Studio - Landmark studies at the EASL Congress 2024 Faculty Thomas Berg (Moderator) Rajiv Jalan (Faculty) Verena Keitel (Faculty) Frank Tacke (Faculty) All EASL Studio Podcasts are available on EASL Campus .
EASL Studio Podcast: Education at the heart of EASL’s mission 12.06.2024 24:55
EASL Studio - Education at the heart of EASL’s mission Faculty Sven Francque (Moderator) Krista Rombouts (Faculty) Rajeshwar Mookerjee (Faculty) Henning Grønbæk (Faculty) All EASL Studio Podcasts are available on EASL Campus .
EASL Studio Podcast: Arrivederci Milano, hallo Amsterdam! 12.06.2024 23:20
Arrivederci Milano, hallo Amsterdam! Faculty Aleksander Krag (Moderator) Debbie Shawcross (Moderator) Cyrielle Caussy (Faculty) Ana Lleo (Faculty) Francesco Negro (Faculty) Vlad Ratziu (Faculty) Virginia Hernández-Gea (Faculty) All EASL Studio Podcasts are available on EASL Campus .
EASL Studio Podcast: What‘s hot in viral hepatitis in 2024? 30.05.2024 50:09
This session covers a wide range of topics relevant to the current landscape of viral hepatitis, including elimination efforts, resistance to direct-acting antivirals (DAAs), surveillance methods during and after therapy. This talk provides you with valuable insights through an up-to-date overview of the latest developments and challenges in the field. Faculty Thomas Berg (Moderator) Jordan Feld (...
EASL Studio Podcast: Endohepatology: The endoscopic liver gold rush 23.05.2024 31:16
This insightful discussion is centred on the burgeoning field of endohepatology, where advanced endoscopic techniques revolutionise hepatology practice. With this episode, explore the broad scope of endoscopic procedures (including EUS-guided liver biopsy, portal pressure measurement, and gastric varices embolisation) and their transformative impact on diagnostics and therapeutic interventions in...
EASL Studio Podcast: Resmetirom: First approved drug for MASH, for whom and for how long? 16.05.2024 35:44
This episode explores the approval of resmetirom for NASH, analysing its integration into clinical practice and patient eligibility. The experts also discuss the role of lifestyle interventions alongside resmetirom, the use of biomarkers for patient selection, treatment monitoring, and the expected landscape changes over the next five years. Faculty Aleksander Krag (Moderator) Naim Alkhouri (Facul...
EASL Studio Podcast: Do we care enough about the importance of DILI/DHILI ? 10.05.2024 38:55
Join us for a critical discussion on the significance of Drug and Herbal & Dietary Supplement-Induced Liver Injury (DHILI). In this episode, the speakers explore the importance of DHILI, assess recent advancements, and deliberate on the obstacles hindering further progress in addressing this pressing healthcare concern. This episode is organised in collaboration with the EASL DHILI Consortium...
EASL Studio Podcast: Assessment of clinically significant portal hypertension in 2024 – Is it time to say goodbye to invasive measurements? 02.05.2024 30:28
In this episode, experts explore the shift away from invasive measurements in assessing clinically significant portal hypertension. The speakers address the crucial data needed to enhance the reliability and applicability of these non-invasive methods and introduce several advanced elastography techniques, shaping the future of portal hypertension assessment. Faculty Bogdan Procopet (Moderator) Ma...
EASL Studio Podcast: YI Choice: Citizen science: Societal engagement in hepatology 28.03.2024 31:19
This episode aims at highlighting the importance of patient and public involvement in research. More precisely, the speakers focus on the importance of involving patients in research, practical steps to involve patients in research, and insights from EASL including engagement of patients in the EASL-Lancet Commission. Faculty Marta Alonso-Peña (Moderator) Kate Jack (Faculty) Marko Korenjak (Facult...
EASL Studio Podcast: Therapy hierarchy in HCC: A new kid on the block 21.03.2024 40:05
This episode centres around an article recently published in the Journal of Hepatology , presenting a new treatment algorithm positioned as an evolution of the BCLC system and aimed at addressing its limitations in the staging and therapy hierarchy for HCC. This discussion covers the implications of this fresh approach in the management of HCC patients, challenging the standard paradigm. Faculty B...
EASL Studio Podcast: Is there a role for measuring blood ammonia in patients with cirrhosis? 14.03.2024 33:41
In this episode, the faculty review the evidence base for ammonia measurement in patients with cirrhosis, exploring whether hyperammonaemia is indicative of a poor prognosis and if erroneous measurements correlate with the efficacy of ammonia-lowering therapies. The debate also extends to the use of ammonia as a potential endpoint in randomised controlled trials for hepatic encephalopathy drugs. F...
EASL Studio Podcast: The impact of policy measure in preventing liver diseases: The Hepahealth II study 07.03.2024 31:57
This episode treats of the Hepahealth II study , which aimed at estimating the impact of policy interventions targeting alcohol and obesity on the incidence of chronic liver disease and primary liver cancer in three European countries. Join our experts in their discussion of this study and of its conclusions. Faculty Patrizia Burra (Moderator) Maria Buti (Faculty) Peter Jepsen (Faculty) Shira Zelb...
EASL Studio Podcast: Alpha-1-antitrypsin deficiency (AATD): A poster child for genetic therapy 29.02.2024 35:59
On the eve of the rare disease day, our guests discuss the compelling reasons why AATD stands out as the prime candidate for gene therapy. This talk addresses the pertinence of the subject in the current research landscape and highlight ongoing global trials opening the door for new opportunities in this field. Faculty Aleksander Krag (Moderator) Aftab Ala (Faculty) Pavel Strnad (Faculty) Alice Tu...
EASL Studio Podcast: JHEP Live: Should the compensated advanced chronic liver disease (cACLD) concept replace cirrhosis? 22.02.2024 31:27
The definition of cACLD is now strongly linked to care and research outcomes such as non invasive diagnosis, reversibility and prevention of decompensation. Thus, what space is left for the use of the old term cirrhosis in clinical practice and research? Faculty Paolo Angeli (Moderator) Guadalupe Garcia-Tsao (Faculty) Valérie Paradis (Faculty) Thomas Reiberger (Faculty) Related episodes EASL Studi...
EASL Studio Podcast: World Cholangiocarcinoma Day: Highlighting guidelines and exploring the horizon beyond 15.02.2024 45:35
In this exclusive session, Thomas Berg and his panelists examine the intricate world of intrahepatic Cholangiocarcinoma (iCCA), following the publication of the EASL clinical practice guidelines on iCCA in 2023. This discussion aim at raising awareness and promoting a deeper understanding of this complex condition, while touching upon the topic of targeted therapies, highlighting the advancements...
EASL Studio Podcast: How to stop recurrent bleeding due to small-intestinal angiodysplasia? 08.02.2024 30:22
The participants focus on the topic of managing recurrent bleeding due to small-intestinal angiodysplasia – a persistent challenge encountered by many hepatologists. Our panel explores effective treatments and interventions, including medications like bevacizumab and thalidomide, alongside the role of endoscopy in diagnosis and management. Faculty Pierre-Emmanuel Rautou (Moderator) Virginia Hernán...
EASL Studio Podcast: Do we solve MASLD by treating obesity? 25.01.2024 33:29
Our speakers explore the latest insights into the adipose tissue-liver axis, focusing on weight-reducing drugs’ current status and the crucial question of who should prescribe them and how efficacy should be monitored. They debate the implications of these drugs, their expected outcomes, and their integration into the toolkit of hepatologists. Don’t miss this opportunity to grasp the evolving dyna...
EASL Studio Podcast: EASL Studio’s holiday reflection: A look back to leap forward 21.12.2023 27:04
Join us for a wrap-up of EASL Studio’s season and a preview of what is to come in 2024! In this special episode, we reminisce about the year’s top hepatology breakthroughs and controversies. This festive discussion highlights the best of the past while offering an exciting glimpse into the future of the evolving world of liver health. Faculty Aleksander Krag (Moderator) Thomas Berg (Faculty) Ahmed...
EASL Studio Podcast: Hepatic encephalopathy: Underdiagnosed and underestimated 14.12.2023 35:56
Hepatic encephalopathy (HE) is a common reversible complication of advanced liver disease characterised by a spectrum of neuropsychiatric abnormalities. Due to its insidious onset, most patients only seek treatment once complications develop, resulting in it being an underdiagnosed and underestimated condition. This EASL Studio episode, organised in collaboration with the International Society for...
EASL Studio Podcast: Basics in decision-making for liver cancer treatment 07.12.2023 33:03
With cases of hepatocellular carcinoma on the rise and representing the end stage of many chronic liver diseases, the treatment of liver cancer has become one of the most dynamic areas in hepatology. The focus of this episode is on answering practical clinical questions, examining trial data, and sharing clinical insights that may be useful for decision-making in daily clinical practice. Faculty T...
EASL Studio Podcast: PSC and AIH overlap syndrome: does it actually exist? 30.11.2023 29:44
This episode explores key aspects of intriguing intersection of autoimmune liver diseases, such as their distinctive presentations in childhood and adulthood and the influence of inflammatory bowel disease on liver disease phenotypes. The speakers also examines the benefits and risks associated with immunosuppressive treatments in managing these complex conditions. Faculty Palak Trivedi (Moderator...
EASL Studio Podcast: The window hypothesis again, or just a closed window? 23.11.2023 32:08
The treatment of liver cirrhosis – currently based on symptomatic management of complications – has barely changed in last 20 years. In this episode, the experts discuss the use of statins, for which there is growing body of evidence of their beneficial effects in patients suffering with cirrhosis. Faculty Thomas Reiberger (Moderator) Juan Gonzalez-Abraldes (Faculty) Elisa Pose (Faculty) Jonel Tre...
EASL Studio Podcast: Why should diabetologists care about the liver? 16.11.2023 36:50
In this episode, participants tackle the relationship between metabolic dysfunction-associated steatotic liver diseases (MASLD) and type 2 diabetes (T2D), exploring their prevalence and the potential for more aggressive outcomes. Experts weigh in on the pressing questions of whether non-invasive test thresholds should be adapted for MASLD patients with T2D and which drugs should take precedence as...
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.